Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
7 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Identification of miRNA modulators to PARP inhibitor response.
DNA Repair (Amst). 2013 Jun 1;12(6):394-402. doi: 10.1016/j.dnarep.2013.02.003. Epub 2013 Apr 6.
DNA Repair (Amst). 2013.
PMID: 23570906
Mechanism of cell killing after ionizing radiation by a dominant negative DNA polymerase beta.
Neijenhuis S, Verwijs-Janssen M, Kasten-Pisula U, Rumping G, Borgmann K, Dikomey E, Begg AC, Vens C.
Neijenhuis S, et al.
DNA Repair (Amst). 2009 Mar 1;8(3):336-46. doi: 10.1016/j.dnarep.2008.11.008. Epub 2008 Dec 27.
DNA Repair (Amst). 2009.
PMID: 19059500
Item in Clipboard
Targeted radiosensitization by the Chk1 inhibitor SAR-020106.
Borst GR, McLaughlin M, Kyula JN, Neijenhuis S, Khan A, Good J, Zaidi S, Powell NG, Meier P, Collins I, Garrett MD, Verheij M, Harrington KJ.
Borst GR, et al. Among authors: neijenhuis s.
Int J Radiat Oncol Biol Phys. 2013 Mar 15;85(4):1110-8. doi: 10.1016/j.ijrobp.2012.08.006. Epub 2012 Sep 14.
Int J Radiat Oncol Biol Phys. 2013.
PMID: 22981708
Item in Clipboard
Radiosensitization by a dominant negative to DNA polymerase beta is DNA polymerase beta-independent and XRCC1-dependent.
Neijenhuis S, Begg AC, Vens C.
Neijenhuis S, et al.
Radiother Oncol. 2005 Aug;76(2):123-8. doi: 10.1016/j.radonc.2005.06.020.
Radiother Oncol. 2005.
PMID: 16024118
Item in Clipboard
Targeted radiosensitization of cells expressing truncated DNA polymerase {beta}.
Neijenhuis S, Verwijs-Janssen M, van den Broek LJ, Begg AC, Vens C.
Neijenhuis S, et al.
Cancer Res. 2010 Nov 1;70(21):8706-14. doi: 10.1158/0008-5472.CAN-09-3901. Epub 2010 Oct 26.
Cancer Res. 2010.
PMID: 20978197
Item in Clipboard
Quantitative reverse transcription-polymerase chain reaction measurement of HASH1 (ASCL1), a marker for small cell lung carcinomas with neuroendocrine features.
Westerman BA, Neijenhuis S, Poutsma A, Steenbergen RD, Breuer RH, Egging M, van Wijk IJ, Oudejans CB.
Westerman BA, et al. Among authors: neijenhuis s.
Clin Cancer Res. 2002 Apr;8(4):1082-6.
Clin Cancer Res. 2002.
PMID: 11948117
Item in Clipboard
Decentralization of Next-Generation RNA Sequencing-Based MammaPrint® and BluePrint® Kit at University Hospitals Leuven and Curie Institute Paris.
Slembrouck L, Darrigues L, Laurent C, Mittempergher L, Delahaye LJ, Vanden Bempt I, Vander Borght S, Vliegen L, Sintubin P, Raynal V, Bohec M, Reyes C, Rapinat A, Helsmoortel C, Jongen L, Hoste G, Neven P, Wildiers H, Smeets A, Nevelsteen I, Punie K, Van Nieuwenhuysen E, Han S, Vincent Salomon A, Laas Faron E, Cynober T, Gentien D, Baulande S, Snel MH, Witteveen AT, Neijenhuis S, Glas AM, Reyal F, Floris G.
Slembrouck L, et al. Among authors: neijenhuis s.
Transl Oncol. 2019 Dec;12(12):1557-1565. doi: 10.1016/j.tranon.2019.08.008. Epub 2019 Sep 9.
Transl Oncol. 2019.
PMID: 31513983
Free PMC article.
Item in Clipboard
Cite
Cite